State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3

Siebert, Uwe, Alagoz, Oguzhan, Bayoumi, Ahmed M., Jahn, Beate, Owens, Douglas K., Cohen, David J., Kuntz, Karen M.·2012·Value in Health

DOI 10.1016/j.jval.2012.06.014

Cited by (494)

Items 101–200 of 494

A method for using real world data in breast cancer modeling
Monika Pobiruchin, Sylvia Bochum, Uwe M. Martens · 2016 · Journal of Biomedical Informatics
Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting
Simon W. Lam, Elizabeth A. Neuner, Thomas G. Fraser, David Delgado, Donald B. Chalfin · 2018 · Infection Control and Hospital Epidemiology
GetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world.
Panayidou, Klea, Gsteiger, Sandro, Egger, Matthias, Kilcher, Gablu, Carreras, Máximo, Efthimiou, Orestis, Debray, Thomas P. A., Trelle, Sven, Hummel, Noemi, on behalf of the GetReal methods review group · 2016 · Research Synthesis Methods
A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention Strategies
Gaby Sroczynski, Artemisa Gogollari, Felicitas Kuehne, Lára R. Hallsson, Martin Widschwendter, Nora Pashayan, Uwe Siebert · 2020 · Cancer Prevention Research
Cost effectiveness and value of information analyses of islet cell transplantation in the management of ‘unstable’ type 1 diabetes mellitus
Klemens Wallner, Andrew M. James Shapiro, Peter Alexander Senior, Christopher J. McCabe · 2016 · BMC Endocrine Disorders
Improving the planning of the GP workforce in Australia: a simulation model incorporating work transitions, health need and service usage
Caroline Laurence, Jonathan D. Karnon · 2016 · Human Resources for Health
Cost-effectiveness of In-Home Cognitive Behavioral Therapy for low-income depressed mothers participating in early childhood prevention programs
Robert T. Ammerman, Peter J. Mallow, John A. Rizzo, Frank W. Putnam, Judith B. Van Ginkel · 2016 · Journal of Affective Disorders
A radiobiological Markov simulation tool for aiding decision making in proton therapy referral
Annabelle M. Austin, Michael John James Douglass, Giang T. Nguyen, Scott N. Penfold · 2017 · Physica Medica
Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: an economic analysis
Jun Zhu, Te Li, Xiaohui Wang, Ming Ye, Jian Qiang Cai, Yuejuan Xu, Bin Yan Wu · 2013 · BMC Cancer
Impact of overweight and obesity on life expectancy, quality-adjusted life years and lifetime costs in the adult population of Ghana
Stella T. Lartey, Lei Si, Thomas Wai-Chun Lung et al. · 2020 · BMJ Global Health
Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States
Kit N. Simpson, Pamela P. Pei, Jörgen Möller, Robert W. Baran, Birgitta Dietz, William C. Woodward, Kristen Migliaccio–Walle, J. Jaime · 2013 · PharmacoEconomics
Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review
Natalia Ruiz‐Negrón, Jyothi Menon, Jordan B. King, Junjie Ma, Brandon Kyle Bellows · 2019 · PharmacoEconomics
Pharmacoeconomic Analyses and Modeling
Dixon Thomas, Mickaël Hiligsmann, Denny John · 2019 · Elsevier eBooks
Cost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S.
David D. Kim, Parke Wilde, Dominique S. Michaud, Junxiu Liu, Lauren Lizewski, Jennifer Onopa, Dariush Mozaffarian, Fang Fang Zhang, John B. Wong · 2019 · American Journal of Preventive Medicine
An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
Arielle G. Bensimon, Zheng‐Yi Zhou, Madeline D. Jenkins, Yan Song, Wei Gao, James Signorovitch, Clemens Krepler, Emilie Scherrer, Jingshu Wang, Raquel Aguiar‐Ibáñez · 2020 · Clinical Drug Investigation
Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction
Michael Grabner, Julja Burchard, Chi Nguyen, Haechung Chung, Nilesh Gangan, J. Jay Boniface, John A. F. Zupancic, Eric J. Stanek · 2021 · ClinicoEconomics and Outcomes Research
Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling
Martha Maria Christine Elwenspoek, Howard H. Z. Thom, Athena Louise Sheppard, Edna Keeney, Rachel O’Donnell, Joni Jackson, Cristina Roadevin, Sarah Dawson, Deborah Lane, Jo Stubbs et al. · 2022 · Health Technology Assessment
Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy
Yao-Jen Chang, Lorenzo G. Gallon, Colleen L. Jay et al. · 2014 · Liver Transplantation
Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan
Eiichi Tanaka, Eisuke Inoue, Rei Yamaguchi et al. · 2016 · Modern Rheumatology
Cost‐Effectiveness Analysis of Second‐Line Chemotherapy Agents for Advanced Gastric Cancer
Simon W. Lam, Maya Wai, Jessica E. Lau, Michael J. McNamara, Marc A. Earl, Belinda L. Udeh · 2016 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
How is disease severity associated with quality of life in psoriasis patients? Evidence from a longitudinal population-based study in Sweden
Kirk Geale, Martin Henriksson, Marcus Schmitt‐Egenolf · 2017 · Health and Quality of Life Outcomes
The cost-utility of stepped-care algorithms according to depression guideline recommendations – Results of a state-transition model analysis
Jolanda A. C. Meeuwissen, Talitha Feenstra, Filip Smit, Matthijs Blankers, Jan Spijker, Claudi Bockting, Anton J.L.M. van Balkom, Erik Buskens · 2018 · Journal of Affective Disorders
Cost-effectiveness of second-line vasopressors for the treatment of septic shock
Simon W. Lam, Erin Frazee Barreto, Rachael A. Scott, KIANOUSH B KASHANI, Ashish Kumar Khanna, Seth R. Bauer · 2019 · Journal of Critical Care
Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study
Benjamin Yaël Gravesteijn, Eline Krijkamp, Jan J.V. Busschbach, Geert Geleijnse, Isabel Retel Helmrich, Sophie M. Bruinsma, Céline van Lint, Ernest van Veen, Ewout Willem Steyerberg, Kees Verhoef et al. · 2021 · Value in Health
The potential health and economic effect of a Body Mass Index decrease in the overweight and obese population in Belgium
Nick Verhaeghe, O. De Greve, Lieven Annemans · 2016 · Public Health
Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis
Liêm Binh Luong Nguyen, Maud Lemoine, Gibril Ndow · 2023 · The Lancet Global Health
Cost–Effectiveness of Different Strategies for Stroke Prevention in Patients with Atrial Fibrillation in a Health Resource-Limited Setting
Bin Yan Wu, Kun Li, Xiaoyan Liu, Ben He · 2013 · Cardiovascular Drugs and Therapy
Climate influences on the cost-effectiveness of vector-based interventions against malaria in elimination scenarios
Paul E. Parham, Dyfrig Arwyn Hughes · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences
Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
Ursula Rochau, Gaby Sroczynski, Dominik Georg Friedrich Wolf, Stefan Ulrich Schmidt, Beate Jahn, Martina Kluibenschaedl, Annette Conrads‐Frank, David Dean Stenehjem, Diana I Brixner, Jerald P. Radich et al. · 2014 · Leukemia & lymphoma/Leukemia and lymphoma
Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan
Akihiro Nishie, Satoshi Goshima, Hiroki Haradome, Etsuro Hatano, Yasuharu Imai, Masatoshi Kudo, Masanori Matsuda, Utaroh Motosugi, Satoshi Saitoh, Kengo Yoshimitsu et al. · 2017 · Clinical Therapeutics
A theoretical foundation for state-transition cohort models in health decision analysis
R. Iskandar · 2018 · PLoS ONE
Cost-Effectiveness of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B in Canada
Feng Tian, Sherilyn K. D. Houle, Mhd Wasem Alsabbagh · 2019 · PharmacoEconomics
The cost-utility of school-based first permanent molar sealants programs: a Markov model
Gerardo Espinoza‐Espinoza, Gilda Corsini, Rubén Rojas, Rodrigo Mariño, Carlos Zaror · 2019 · BMC Oral Health
Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients
Simone A. Huygens, Isaac Corro Ramos, Carlijn V. C. Bouten, Jolanda Kluin, Shih Ting Chiu, Gary L. Grunkemeier, Johanna J.M. Takkenberg, Maureen Rutten‐van Mölken · 2020 · The European Journal of Health Economics
Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis
Kanila Perera, Ning Kam, Zanfina Ademi, Danny Liew, Ella Zomer · 2020 · Journal of clinical lipidology
Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis
Paolo Angelo Cortesi, Lorenzo Giovanni Mantovani, Antonio Ciaccio · 2015 · American Journal of Transplantation
Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
Louise Baschet, Sandrine Bourguignon, Sébastien Marque, Isabelle Durand‐Zaleski, Emmanuel Teíger, Fanny Wilquin, Karine Lévesque · 2016 · Open Heart
Simulation Modeling of the Impact of Proposed New Simultaneous Liver and Kidney Transplantation Policies
Yao-Jen Chang, Lorenzo G. Gallon, Kirti Shetty et al. · 2014 · Transplantation
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer
Mieke Van Hemelrijck, Hans Garmo, Lars Lindhagen · 2016 · European Urology
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation
Mathilde Peron, Alexis Llewellyn, Thirimon Moe‐Byrne, Simon Walker, Matthew Walton, Melissa Harden, Stephen Palmer, Mark C. Simmonds · 2018 · Health Technology Assessment
Optimization of Sequential Decision Making for Chronic Diseases: From Data to Decisions
Brian T. Denton · 2018
Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P
Hideki Murasawa, Takayuki Sugiyama, Yuki Matsuoka, Takashi Okabe, Amiko Hino, Nobumichi Tanaka, Mikio Sugimoto, Masafumi Oyama, Kiyohide Fujimoto, Shigeo Horie et al. · 2019 · Quality of Life Research
Cost-effectiveness of physical activity interventions in adolescents: model development and illustration using two exemplar interventions
Vijay S. Gc, Marc Suhrcke, Andrew J. Atkin, Esther M. F. van Sluijs, David Turner · 2019 · BMJ Open
Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms
Joost G. E. Verbeek, Vera Atema, Janne C. Mewes, Marieke van Leeuwen, Hester S. A. Oldenburg, Marc van Beurden, Myra Sally Hunter, Wim H. van Harten, Neil K. Aaronson, Valesca P. Retèl · 2019 · Breast Cancer Research and Treatment
A Multidimensional Array Representation of State-Transition Model Dynamics
Krijkamp, Eline M., Alarid-Escudero, Fernando, Enns, Eva A., Pechlivanoglou, Petros, Hunink, M.G. Myriam, Yang, Alan, Jalal, Hawre J. · 2020 · Medical Decision Making
Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer—A Systematic Review
G. Sroczynski, A. Gogollari, A. Conrads-Frank, L. Hallsson, N. Pashayan, M. Widschwendter, U. Siebert · 2020 · Cancers
Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals
Tushar Srivastava, Nicholas R. Latimer, Paul Tappenden · 2021 · PharmacoEconomics
Superabsorbent wound dressings versus foams dressings for the management of moderate-to-highly exuding venous leg ulcers in French settings: An early stage model-based economic evaluation
Vladica M. Veličković, Pablo Arija Prieto, Milica Krga · 2022 · Journal of Tissue Viability
Improving shared decision-making about cancer treatment through design-based data-driven decision-support tools and redesigning care paths: an overview of the 4D PICTURE project
Judith A C Rietjens, Ingeborg P. M. Griffioen, Jorge Sierra-Pérez, Gaby Sroczynski, Uwe Siebert, Alena Buyx, Barbara Perić, Inge Marie Svane, J. Brands, Karina Dahl Steffensen et al. · 2024 · Palliative Care and Social Practice
Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina
Mariano Anibal Giorgi, Christian Caroli, Norberto Giglio, Paula Micone, Eleonora Aiello, Cristina Vulcano, Julia Blanco, Bonnie M.K. Donato, Joaquín Mould Quevedo · 2015 · Health Economics Review
Diretriz metodológica para estudos de avaliação econômica de tecnologias em saúde no Brasil
Rodrigo Antonini Ribeiro, Jeruza Lavanholi Neyeloff, Alexander Itria, Vânia Cristina Canuto Santos, Cid Manso de Mello Vianna, Everton Nunes da Silva, Flávia Tavares Silva Elias, Roberta Moreira Wichmann, Kathiaja Miranda Souza, Luciane Nascimento Cruz et al. · 2016 · Jornal Brasileiro de Economia da Saúde
Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online
Beate Jahn, Ursula Rochau, Christina Kurzthaler et al. · 2017 · BMC Cancer
Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening
Juliana Yukari Kodaira Viscondi, Christine Grützmann Faustino, Alessandro Gonçalves Campolina, Alexander Itria, Patrícia Coelho de Soárez · 2018 · Clinics
Comparative Value of Cholinesterase Inhibitors and Memantine in Persons with Moderate-to-Severe Alzheimer’s Disease in the United States: A Cost-Effectiveness Analysis
Ismaeel U. Yunusa, Saud Mohammad Alsahali, Amey Rane, Tewodros Eguale · 2021 · Journal of Alzheimer s Disease Reports
Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer
Steven R. Alberts, Tiffany M. Yu, Robert J. Behrens, Lindsay Anne Renfro, Geetika Srivastava, Gamini S. Soori, Shaker R. Dakhil, Rex Bradford Mowat, J. Philip Kuebler, George P. Kim et al. · 2014 · PharmacoEconomics
Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis
Louisa G. Gordon, Haitham Tuffaha, Robbie James · 2017 · Urologic Oncology Seminars and Original Investigations
Testing strategies for couple engagement in prevention of mother-to-child transmission of HIV and family health in Kenya: study protocol for a randomized controlled trial
Zachary Kwena, Liza Kimbo, Lynae A. Darbes, Abigail M. Hatcher, Anna Helová, George Owino, Harsha Thirumurthy, Elizabeth Anne Bukusi, Thomas Braun, Meredith L. Kilgore et al. · 2021 · Trials
Cost‐effectiveness analysis of emicizumab prophylaxis in patients with haemophilia A in India
Tulika Seth, M. Joseph John, Prantar Chakrabarti, Chandrakala Shanmukhaiah, Shailendra Prasad Verma, Nita Radhakrishnan, Tuphan Kanti Dolai · 2023 · Haemophilia
Simulation-based economic evaluation of the Wolbachia method in Brazil: a cost-effective strategy for dengue control
Ivan Ricardo Zimmermann, Ricardo Ribeiro Alves Fernandes, Márcia Gisele Santos da Costa · 2024 · The Lancet Regional Health - Americas
ROBVALU: a tool for assessing risk of bias in studies about people’s values, utilities, or importance of health outcomes
Samer G. Karam, Yuan Zhang, Hector Pardo Hernandez, Uwe Siebert, Laura Koopman, Jane Noyes, Jean‐Éric Tarride, Adrienne Stevens, Vivian Andrea Welch, Zuleika Saz‐Parkinson et al. · 2024 · BMJ
Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?
Andrea Marcellusi, Raffaella Viti, Francesco Damele · 2016 · Clinical Drug Investigation
Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat ® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy
Carl Selya-Hammer, Núria González-Rojas, Michael Baldwin · 2016 · Therapeutic Advances in Respiratory Disease
Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis
Rhodri Saunders, Anthony James Comerota, Audrey Ozols, Rafael Torrejón Torres, Kwok Ming Ho · 2018 · ClinicoEconomics and Outcomes Research
Assessing the cost‐effectiveness of a fluoride varnish programme in Chile: The use of a decision analytic model in dentistry
Raul A. Palacio, Jing Shen, Luke David Vale, Christopher R. Vernazza · 2019 · Community Dentistry And Oral Epidemiology
Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis
Kanila Perera, Zanfina Ademi, Danny Liew, Ella Zomer · 2019 · European Journal of Preventive Cardiology
Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study
Angela Kather, Habibollah Arefian, Claus Schneider · 2025 · PLoS Medicine
Cost effectiveness and return on investment of a scalable community weight loss intervention
Tzeyu L. Michaud, Wen You, Kathryn Elizabeth Wilson, Dejun Su, Todd J. McGuire, Fabio A. Almeida, Amy L. Bayer, Paul Andrew Estabrooks · 2017 · Preventive Medicine
Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study
Jaclyn Marie Beca, Kelvin Chan, David M. J. Naimark · 2021 · BMC Medical Research Methodology
A scoping review of metamodeling applications and opportunities for advanced health economic analyses
Koen Degeling, Maarten J. IJzerman, Hendrik Koffijberg · 2018 · Expert Review of Pharmacoeconomics & Outcomes Research
Causal evidence in health decision making: methodological approaches of causal inference and health decision science
Felicitas Kühne, Michael Schomaker, Igor Stojkov, Beate Jahn, Annette Conrads‐Frank, Silke Siebert, Gaby Sroczynski, Sibylle Puntscher, Daniela Schmid, Petra Schnell‐Inderst et al. · 2022 · PubMed Central
Simulating future public health benefits of tobacco control interventions: a systematic review of models
Ankur Singh, Nick Wilson, Tony A Blakely · 2020 · Tobacco Control
Dehydrated human amnion and chorion allograft versus standard of care alone in treatment of Wagner 1 diabetic foot ulcers: a trial-based health economics study
Marissa Janine Carter · 2020 · Journal of Medical Economics
Health variations among breast-cancer patients from different disease states: evidence from China
Qing Yang, Xuexin Yu, Wei Zhang · 2020 · BMC Health Services Research
Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic
Cristino, Joaquim, Finek, Jíndřich, Jandova, Petra, Kolek, Martin, Pásztor, Bálint, Giannopoulou, Christina, Qian, Yi, Brezina, Tomas, Lothgren, Mickael · 2017 · Journal of Medical Economics
Validation of a DICE Simulation Against a Discrete Event Simulation Implemented Entirely in Code
Jörgen Möller, Sarah Davis, Matt Stevenson, J. Jaime · 2017 · PharmacoEconomics
Public health economic evaluation of different European Union–level policy options aimed at reducing population dietary trans fat intake
Carlos Martín Saborido, Theodora Mouratidou, Anastasia Livaniou, Sandra Caldeira, Jan Wollgast · 2016 · American Journal of Clinical Nutrition
Long-Term Outcomes of Prostate-Specific Membrane Antigen–PET Imaging of Recurrent Prostate Cancer
Natalia Kunst, Jessica B. Long, Sarah J. Westvold, Preston C. Sprenkle, Isaac Yi Kim, Lawrence A. Saperstein, Maximilian J. Rabil, Umar Ghaffar, Robert Jeffrey Karnes, Xiaomei Ma et al. · 2024 · JAMA Network Open
Estimating State Transitions for Opioid Use Disorders
Emanuel Krebs, Jeong Eun Min, Elizabeth Evans, Libo Li, Lei Liu, David Y. C. Huang, Darren I. Urada, Thomas H Kerr, Yih‐Ing Hser, Bohdan Nosyk · 2016 · Medical Decision Making
Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences
Tereza Lanitis, Robert J. Leipold, Melissa Hamilton, Dale A. Rublee, Peter Quon, Chantelle Browne, Alexander Thomas Cohen · 2017 · BMC Health Services Research
Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection
Shelby L. Corman, Elamin H. Elbasha, Steven N. Michalopoulos, Chizoba N. Nwankwo · 2017 · Value in Health
Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer
Koen Degeling, Stefano Schivo, Niven Mehra, Hendrik Koffijberg, Rom Langerak, Johann Sebastian De Bono, Maarten J. IJzerman · 2017 · Value in Health
Paramedic Acute Stroke Treatment Assessment (PASTA): study protocol for a randomised controlled trial
Christopher Price, Lisa C. Shaw, Peter Dodd, Catherine Exley, Darren Flynn, Richard P. Francis, Saiful Islam, Mehdi Javanbakht, Rachel Lakey, Joanne E Lally et al. · 2019 · Trials
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada
Ian Cromwell, Dean A. Regier, Stuart J Peacock · 2016 · The Oncologist
The value-based price of transformative gene therapy for sickle cell disease: a modeling analysis
George Morgan, Emily Back, Martin W. Besser, Timothy B. Hallett, Gregory F. Guzauskas · 2024 · Scientific Reports
Brain Network Dynamics and Multiscale Modeling of Neurodegenerative Disorders: A Review
Hina Shaheen, Roderick Melnik · 2025 · IEEE Access
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
Craig Bennison, Stephanie Stephens, Bénédicte Lescrauwaet, Ben van Hout, Timothy L. Jackson · 2016 · Journal of Market Access & Health Policy
Systematic review of model-based economic evaluations of heart valve implantations
Simone A. Huygens, Johanna J.M. Takkenberg, Maureen Rutten‐van Mölken · 2017 · The European Journal of Health Economics
Using Observational Data to Calibrate Simulation Models
Eleanor J. Murray, James M. Robins, George R. Seage, Sara Lodi, Emily Parker Hyle, Krishna P. Reddy, Kenneth A. Freedberg, Miguel Ángel Hernán · 2017 · Medical Decision Making
Cost‐effectiveness of treatments for superficial venous reflux in patients with chronic venous ulceration
David Mark Epstein, Manjit Gohel, Francine Heatley · 2018 · BJS Open
Microsimulation Modeling in Food Policy: A Scoping Review of Methodological Aspects
Elly Mertens, Els Genbrugge, Junior Ocira, José Luis Peñalvo · 2021 · Advances in Nutrition
The cost-effectiveness of unilateral magnetic resonance-guided focused ultrasound in comparison with unilateral deep brain stimulation for the treatment of medically refractory essential tremor in England
Ayesha Jameel, Anne Meiwald, Peter G. Bain, Neekhil A Patel, Dipankar Nandi, Brynmor Jones, Georgie Weston, Elisabeth Jane Adams, Wladyslaw M.W. Gedroyc · 2022 · British Journal of Radiology
High-Flow Nasal Cannula in Bronchiolitis: Modeling the Economic Effects of a Ward-Based Protocol
Catherine Collins, Titus Chan, Joan S. Roberts · 2017 · Hospital Pediatrics
Using State Transition Models To Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension
Russell Edward Lewis, Dimitrios P. Kontoyiannis, Pierluigi Viale, Eric Sarpong · 2019 · Antimicrobial Agents and Chemotherapy
How to model temporal changes in comorbidity for cancer patients using prospective cohort data
Lars Lindhagen, Mieke Van Hemelrijck, David Robinson · 2015 · BMC Medical Informatics and Decision Making
Cost-utility Analysis of Cochlear Implantation in Adults With Single-sided Deafness: Austrian and German Perspective
Josef Seebacher, Franz Muigg, Heike Kühn · 2021 · Otology & Neurotology
Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluations
Bernice Tsoi, Daria J. O’Reilly, Jathishinie Jegathisawaran, JE Tarride, Gord Blackhouse, Ron A. Goeree · 2015 · BMC Research Notes
Effective but costly: How to tackle difficult trade‐offs in evaluating health improving technologies in liver diseases
Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi, Mario Strazzabosco · 2016 · Hepatology
Modeling the coronavirus disease 2019 pandemic: A comprehensive guide of infectious disease and decision-analytic models
Stephen Mac, Sharmistha Mishra, Raphael Ximenes, Kali A Barrett, Yasín A. Khan, David M. J. Naimark, Beate Sander · 2020 · Journal of Clinical Epidemiology
Field Trauma Triage among Older Adults: A Cost-Effectiveness Analysis
Brandon C Maughan, Amber Lin, Aaron Brandon Caughey, Eileen M Bulger, K John McConnell, Susan Malveau, Denise Griffiths, Craig D Newgard · 2022 · Journal of the American College of Surgeons
Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype
Laura Hörster, Richard F. Schlenk, Michael Stadler et al. · 2017 · Leukemia Research